Periscope Capital’s Healthcare AI Acquisition Corp. Warrants HAIAW Stock Holding History

Periscope Capital’s Portfolio HAIAW Stock Details HAIAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-526,948	Closed	-$14.4K	–	252
2024 Q3	$14.4K	Sell	526,948 -38,052	-7%	-$1.28K	0.01%	167
2024 Q2	$29.6K	Sell	565,000 -360,000	-39%	-$15K	0.01%	174
2024 Q1	$36.3K	Hold	925,000	–	–	0.01%	247
2023 Q4	$23.3K	Hold	925,000	–	–	﹤0.01%	322
2023 Q3	$40.7K	Hold	925,000	–	–	﹤0.01%	393
2023 Q2	$80.9K	Hold	925,000	–	–	0.01%	378
2023 Q1	$130K	Buy	925,000 +224,997	+32%	+$21.8K	0.01%	405
2022 Q4	$46.7K	Buy	700,003 +370,357	+112%	+$23.7K	﹤0.01%	586
2022 Q3	$47K	Buy	+329,646	New	+$56.6K	﹤0.01%	718

Other funds holding HAIAW

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Periscope Capital's HAIAW Position: Q4 2024 in Review

Periscope Capital sold out of Healthcare AI Acquisition Corp. Warrants (HAIAW) in Q4 2024, closing a stake of 526,948 shares — an estimated $14.4K sold.

Periscope Capital first reported a position in HAIAW in Q3 2022 and held it in 9 quarters. The position peaked at $130K in Q1 2023. 3 funds tracked by Wall St. Rank hold HAIAW as of Q4 2024.

Periscope Capital reported no remaining Healthcare AI Acquisition Corp. Warrants position as of Q4 2024 after selling out during the quarter.
Periscope Capital sold 526,948 Healthcare AI Acquisition Corp. Warrants shares in Q4 2024, an estimated $14.4K.
Periscope Capital first reported a position in Healthcare AI Acquisition Corp. Warrants in Q3 2022 and held it in 9 quarters.
Periscope Capital's Healthcare AI Acquisition Corp. Warrants position peaked at $130K in Q1 2023.
3 funds tracked by Wall St. Rank held Healthcare AI Acquisition Corp. Warrants as of Q4 2024.

Based on Periscope Capital's 13F filing for Q4 2024, filed 10 Feb 2025.